Study S002147

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity - a Pragmatic Randomized Trial

ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT03799198
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 200
Start: 2019-01-07
Primary completion: 2020-05-22
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: OTHER:Weight Management Program (WMP); DRUG:Medication for chronic weight management (Rx)
Results posted: TRUE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1218-8104

Registered primary outcomes

Change in Body Weight [Month 0, month 12]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0027799	Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial. Pantalone KM, JAMA network open	2021	Randomized trial	PMID 34255049 DOI	cites ClinicalTrials.gov:NCT03799198; registry reference DERIVED:34255049